Targeting DNA damage repair in small cell lung cancer and the biomarker landscape

Small cell lung cancer (SCLC) is an aggressive malignancy that accounts for 14% of all lung cancer diagnoses. Despite decades of active research, treatment options for SCLC are limited and resistance to the few Food and Drug Administration (FDA) approved therapies develops rapidly. With no approved...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Sen, Triparna, Gay, Carl M., Byers, Lauren Averett
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2018
Subjects:
Review Article on Small Cell Lung Cancer: New Models, Markers and Beyond
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5835589/
https://ncbi.nlm.nih.gov/pubmed/29535912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.02.03
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items